Annexon Inc (ANNX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $747.79M
Last updated: Nov 17, 2026 at 11:05 AM ET
Annexon Inc (ANNX) Stock Forecast
Analysts expect Annexon (ANNX) to earn -$1.02 per share in the fiscal year ending Dec 31, 2026. Of 10 analysts, 8 rate the stock Buy or Strong Buy, 2 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 2 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 10 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 80% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 2 | 20.0% |
| Buy | 6 | 60.0% |
| Hold | 2 | 20.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 10
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a larger loss.
- Fiscal year ending Dec 31, 2026
- -$1.02
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$1.05
- EPS consensus, revenue $34.52M
- Next report
- Mar 29, 2027
- Confirmed, after the close
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$1.02 | -$1.05 to -$0.98 | 5 | N/A | N/A | 8 |
| Dec 31, 2027 | -$1.05 | -$1.39 to -$0.69 | 6 | $34.52M | N/A | 10 |
Quarterly Estimates
The EPS consensus rises from -$0.27 for the quarter ending Dec 31, 2026 to -$0.22 for the quarter ending Mar 31, 2027.
EPS range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.27 | -$0.29 to -$0.24 | 13 | N/A | N/A | 13 |
| Mar 31, 2027 | -$0.22 | -$0.28 to -$0.10 | 5 | $7.73M | N/A | 6 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 3 upward and 3 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 2 |
| Fiscal year ending Dec 31, 2027 | 2 | 1 |
| Quarter ending Mar 31, 2027 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$1.05.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$1.02 | -$1.05 | -$1.05 | -$1.05 | -$1.05 | N/A |
| Fiscal year ending Dec 31, 2027 | -$1.05 | -$1.07 | -$1.09 | -$1.08 | -$1.09 | N/A |
| Quarter ending Mar 31, 2027 | -$0.22 | -$0.22 | -$0.22 | -$0.22 | -$0.21 | N/A |
Frequently Asked Questions About ANNX
What is the ANNX stock forecast?
Consensus analyst estimates put Annexon's EPS at -$1.02 for the fiscal year ending Dec 31, 2026. The consensus rating from 10 analysts is Buy.
How do analysts rate ANNX stock?
Of 10 analysts covering Annexon, 2 rate it Strong Buy, 6 Buy, 2 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from ANNX next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.02, with estimates from -$1.05 to -$0.98 from 5 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$1.05, with estimates from -$1.39 to -$0.69 from 6 analysts.
What revenue do analysts expect from Annexon next year?
For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $34.52M.
How many analysts cover ANNX?
10 analysts rate Annexon stock, and 5 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
ANNX pages: Overview, Earnings, Forecast, Financials, Competitors